Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tailoring cell therapies for diabetic metabolic phenotypes: a comparative study on the efficacy of various umbilical cord-derived cell regimens.

Stem cells translational medicine - 11 Feb 2025

Wang Lingshu, Wang Liming, He Falian, Song Jia, Qiao Jingting, Qin Jun, Chen Li, Hou Xinguo

Abstract excerpt

Given the high heterogeneity of type 2 diabetes mellitus (T2DM), it is imperative to develop personalized stem cell infusion regimen for targeted metabolic phenotype in order to ensure optimal therapeutic efficacy. In this study, we conducted a comparative analysis of 4 infusion regimens involving single and repeated infusions of human umbilical cord Wharton's jelly-derived MSCs (hucMSCs), single infusions of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell- and Tissue-Based Therapy
Share to Diabetes Mellitus, Experimental

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fetal Blood

Share to Insulin-Secreting Cells

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Rats, Sprague-Dawley

Share to Umbilical Cord

Source

Open in PubMed Open full text

Identifiers

PMID: 39560969
DOI: 10.1093/stcltm/szae083
PMCID: PMC11878779

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tailoring cell therapies for diabetic metabolic phenotypes: a comparative study on the efficacy of various umbilical cord-derived cell regimens.PMID 39560969Read ↗

Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 DiabetesSemantic proximity Read ↗

Comparison of human isogeneic Wharton’s jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulationSemantic proximity Read ↗

Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?Semantic proximity Read ↗

Combination of 20(R)-Rg3 and HUCMSCs Alleviates Type 2 Diabetes Mellitus in C57BL/6 Mice by Activating the PI3K/Akt Signaling PathwaySemantic proximity Read ↗

Novel Treatment Modalities of Type 1 Diabetes Mellitus: Opportunities and ChallengesSemantic proximity Read ↗

Diabetes treatment: A rapid review of the current and future scope of stem cell researchSemantic proximity Read ↗

Stem cells as a therapeutic target for diabetesSemantic proximity Read ↗

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 DiabetesSemantic proximity Read ↗

Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic ProgenitorsSemantic proximity Read ↗

Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications.Semantic proximity Read ↗

Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A ReviewSemantic proximity Read ↗

Human umbilical cord mesenchymal stem cells for the treatment of systemic lupus erythematosus via glucose metabolism of CD4 + T cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.